TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
08/09

DJ TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) slipped 3.52% to $1.06 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.98% to 21,450.02 and the Dow Jones Industrial Average rising 0.47% to 44,175.61.

This was the stock's second consecutive day of losses.

TherapeuticsMD Inc. closed 56.50% short of its 52-week high of $2.44, which the company reached on January 3rd.

The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ fell 0.41% to $198.05.

Trading volume (18,550) remained 25,763 below its 50-day average volume of 44,313.

Data source: Dow Jones Market Data, FactSet. Data compiled August 8, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 08, 2025 17:30 ET (21:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10